Chronic Disease Management

You are here: Home » Chronic Disease Management

Healthcare Europa is now starting to write extensively on chronic disease management projects in Europe.

Recent articles

Interview: Dr Jan Van Emelen, Association Internationale de la Mutualité Aug 31, 2009: Chronic diseases cost around 75% of healthcare budgets and account for 80% of premature deaths in Europe so it is an area of great interest for the mutual insurers who meet medical treatment costs across much of Europe. As new methodologies emerge to treat chronic diseases, so the role of the mutual insurers will change. We interview Dr Jan Van Emelen, who heads up the working group on disease management at the Association Internationale de la Mutualité (International Association of Mutuals), on this change of role and on what needs to be done to re-engineer healthcare in the 21st century.

Can you halve hospitalisation rates? Jul 29, 2009: We interview a man running a chronic disease management programme in England which in the first two years suggests that hospital admissions in the group receiving the service have reduced by 52% and visits to family doctors by 33% - Andrew Donald, chief operating officer at NHS Birmingham East and North.

INTERVIEW: Chris Coloian, Senior Vice President, Health Dialog Jul 15, 2009: We talk to Chris Coloian, Senior Vice President Health Services at Health Dialog, a US population health and health improvement company owned by UK healthcare insurer BUPA....

HOLD your breath for the results Jun 8, 2009: The next six months will provide the real evidence on the latest generation of chronic disease management programmes in Europe...

PRIVATE SECTOR chronic and preventive treatment to soar May 18, 2009: BUPA's regional Sofia programme to help French diabetics looks set to go national. Meanwhile, German insurers are waiting with bated breath to see whether US player Healthways has delivered the goods for DAK. And in the UK, private hospital chain Nuffield says its move into gyms has worked well.

Managing chronic and preventive healthcare programmes could become big business for private providers in Europe.